Search Results 11-20 of 16233 for Assay

  1. Point of Care Lateral Flow Assay for Coccidioidomycosis - Mayo Clinic

    About this study. The purpose of this study is to test the accuracy of a point-of-care lateral flow assay for coccidioidomycosis. In seropositive patients ...

  2. CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung (DELFI-L201) - Mayo Clinic

    CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung (DELFI-L201) · Overview · Participation eligibility · Participating Mayo ...

  3. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR) - Mayo Clinic

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR) · Overview · Participation eligibility.

  4. Elisa Eosinophil Peroxidase Assay vs. Validation of a Lateral Flow in Nasal Samples - Mayo Clinic

    About this study. The purpose of this study is to compare lateral flow assay eosinophil peroxidase (LFA-EPX) with ELISA-EPX ...

  5. Detection of Esophageal Cancer by Assay of Novel Methylated DNA Markers in Plasma - Mayo Clinic

    The purpose of the study is to see if the plasma assay of MDMs using optimized markers and analytically sensitive assays will detect early-stage esophageal ...

  6. Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol - Mayo Clinic

    Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol · Overview · Participation eligibility · Participating Mayo Clinic ...

  7. Validation of a Blood Assay for the Detection of BRAF Mutation Status in Patients with Metastatic Melanoma - Mayo Clinic

    The purpose of this study is to validate an internally developed assay for the detection of BRAF V600E mutations in cfDNA from the peripheral blood of patients ...

  8. Novel MOG assay aids diagnosis of demyelinating diseases - Mayo Clinic

    Mayo Clinic has developed the first test available in the United States to identify the myelin oligodendrocyte glycoprotein (MOG) antibody in patients' ...

  9. A Study to Refine and Modify the Granulocyte Antibody Test to Provide Patients the Most Sensitive and Accurate Blood Serum Assay Available. - Mayo Clinic

    A Study to Refine and Modify the Granulocyte Antibody Test to Provide Patients the Most Sensitive and Accurate Blood Serum Assay Available. · Share · Facebook ...

  10. Diagnostic and Prognostic Validity of Tissue-based Biomarker Assay for Acute Graft-versus-host Disease of the Skin: A Retrospective Study - Mayo Clinic

    ... assay, the aim is to perform a multi-institution, retrospective study of our assay compared with the current clinical gold standard (clinicopathologic ...